X1 Esports and Entertainment Ltd has announced a definitive agreement to acquire Tyrus, LLC, an influencer management firm empowering gamers, content creators and influencers. Tyrus Talent Services specializes in working with YouTube, TikTok and Twitch content creators, brand ambassadors and brands across social media channels. The goal of the acquisition is intended to expand X1 Esports’ reach into the Gen Z demographic and add additional revenue streams, the company said. “The Tyrus platform expertly bridges the gap between international brands and the gaming ecosystem,” X1 CEO Mark Elfenbein said in a statement. “The addition of the company to our portfolio will help to establish X1 as an advertising sales organization with access to some of the most sought-after content creators in the video games category.”
First Mining Gold Corp revealed that it has offered to buy private firm Beattie Gold Mines Ltd and is set to make other acquisitions, in total deals worth around C$24 million, which will consolidate one of the largest advanced, undeveloped gold projects in Canada and create a multi-million-ounce district. The company has made an offer to buy Beattie, in which it already owns a 25% stake, and which owns the former Beattie mining concession that forms a large part of the Duparquet gold project in Quebec, Canada. Concurrent with the Beattie offer, First Mining has struck share purchase deals to buy 258 Manitoba and 269 Canada, which it does not already own. These deals are conditional on the Beattie offer, and will close on the same day, which is expected to be in mid-September this year. The total consideration of the Beattie offer is $4.43641 cash per Beattie Gold share and 35 First Mining shares per Beattie Gold share and the total consideration of the concurrent transactions is C$2.5 million in cash and the issue of 20 million First Mining shares.
Railtown AI Technologies Inc has announced the release of Railtown Root Cause Discovery for the popular programming language Node JS. Adding a Node JS solution to its expanding lineup, which includes the .NET and JavaScript solutions, exposes Railtown’s machine learning services to an even bigger and broader marketplace of developers, applications and customers, the company said. It added that this uniquely positions the company to be the Single Source of Truth for Root Cause Discovery for both the back end and the front end of any application.
Copper Fox Metals Inc has updated investors on its Schaft Creek joint venture (SCJV) in British Columbia, where drilling for this year’s planned 5,000 metre (m) program has kicked off. Mining major Teck Resources Ltd Is the operator of the copper-gold-molybdenum-silver venture and holds a 75% stake in the property, while Copper Fox has the remaining 25%. “We are pleased to see the 2022 field program getting underway at Schaft Creek,” said Elmer B. Stewart, the CEO of Copper Fox, in a statement.”In addition to the field program, the SCJV is advancing several desktop initiatives, including investigating the potential to reduce the construction timeline. The results of the 2022 activities will strengthen project base case metallurgical predictions and guide the potential 2023 geotechnical program, increase density and type of environmental baseline data to better reflect current project configuration and regulatory requirements,” he added.
PyroGenesis Canada Inc said its high-quality plasma-atomized metal powders business line has reached new production milestones as the company eyes new markets amid increases in global demand for metal powder. In a corporate update, PyroGenesis told investors that NexGen Plasma Atomization, its patent-pending revolutionary plasma atomized metal powder production process, for use in 3D printing by additive manufacturers, targeted higher production rates, narrower particle size distribution (PSD), and had the advantage of being able to shift the bulk PSD into a more desirable distribution when compared to conventional plasma atomization. PyroGenesis CEO P Peter Pascali said that over the past three years, PyroGenesis had completed a series of intricate production steps as it readied the NexGen Plasma Atomization system.
Royal Helium Ltd said it has begun drilling its first well in the Val Marie field located in southwestern Saskatchewan near the Canada-US border. Val Marie-1 is located on the southernmost of three large land blocks in the Val Marie field which encompasses 13,000 hectares of the Canadian portion of the Bowdoin Dome. Royal Helium contracted Stampede Drilling to drill the directional helium well located at 9-20-1-14W3 to a vertical depth of approximately 2,600 meters. The company said it anticipates drilling operations will take approximately two weeks to be followed by a service rig to complete and test the well. Results will be announced as they are received, it added. In a statement, Shayne Neigum, Royal Helium’s Well Operations manager commented: “Utilizing the newly acquired proprietary 2D seismic and trade seismic, historical maps, and offset wells in the area, the Royal exploration team is excited to test one of several prominent structural features at Val Marie which sits atop the Bowdoin Dome.”
Empress Royalty Corp said it has received the first payable silver ounces from the silver stream agreement on the Tahuehueto Mine, located in Durango, Mexico, and 100% owned and operated by Altaley Mining Corporation. “I am excited to announce Empress has received its first payment of silver ounces from the Tahuehueto mine. It’s only been 12 months since the Tahuehueto silver stream was completed and this is a major milestone to see a development asset move forward to generate revenue for the Company”, said Alexandra Woodyer Sherron, CEO and president of Empress in a statement. “Tahuehueto is an exceptional asset which is expected to generate significant revenue for Empress. It gives Empress direct exposure to silver and combined with our low G&A provides an effective hedge against inflation pressures as seen in other industries. Empress continues to build a strong portfolio of revenue-generating gold and silver royalties and streams and Tahuehueto demonstrates our ability to deliver value to our shareholders,” she added.
Loncor Gold Inc has said it is hoping to develop a second mining district in the Ngayu greenstone gold belt in the Democratic Republic of the Congo. The company announced that it has applied for an exploitation permit for the potential development of its Makapela gold resource, which boasts an indicated resource of 614,200 ounces of gold and an inferred resource of 549,600 ounces at a 2.75 grams per ton (g/t) gold (Au) cutoff. Makapela is located around 50 kilometres from Loncor’s flagship Adumbi deposit.
Algernon Pharmaceuticals Inc has shared positive topline data showing it has met the co-primary endpoint in the Phase 2 proof of concept study evaluating its repurposed drug NP-120 (Ifenprodil) for the potential treatment of idiopathic pulmonary fibrosis (IPF), a disease that causes scarring (fibrosis) of the lungs and chronic cough. In the Vancouver-based clinical-stage pharma company’s study, 65% of the 20 patients had stable or improved forced vital capacity (FVC) over the 12-week treatment period with statistical significance when compared to an anticipated placebo effect of 40%. FVC is the amount of air that can be forcibly exhaled from one’s lungs after taking the deepest breath possible. To evaluate the efficacy of NP-120 in IPF patients, lung function in the trial was measured by FVC, which was taken for each patient at baseline, and then again at 12 weeks. Patients whose FVC declined were classified as non-responders, while those whose FVC improved or remained stable were classified as responders. The primary endpoint of the IPF part of the study was the proportion of patients who responded.
ACME Lithium Inc has reported that an airborne geophysical survey has begun at its 11,803-acre Shatford and Cat-Euclid Lake projects in south eastern Manitoba, Canada. Dias Airborne is carrying out the work with its QMAGT system – the most advanced airborne magnetic system currently commercially available, said ACME. In all, 1,989 line kilometres (km) will be flown at a 65-metre (m) line spacing and at a sensor height of 35m or at the safest height above the tree canopy.
Tiidal Gaming Group Corp has announced that Justin Reguly, a professional player for the company’s wholly-owned subsidiary Lazarus Esports, has won the 2022 North American NHL Gaming World Championship (NHL GWC). Reguly, also known as ‘LZR Regs’, was crowned the North American champion in the NHL GWC on July 6, 2022, and was awarded a cash prize of $26,000. “We would like to congratulate ‘LZR Regs’ for winning the North American Gaming World Championship,” Tiidal Gaming’s chief gaming officer Charlie Watson said in a statement.
Doubleview Gold Corp said it has closed the third and final tranche of its non-brokered flow-through and non-flow-through private placement for gross proceeds of $541,000. Combined with the previous two tranches as announced on June 21 and July 05, 2022, the company has raised a total of $3,068,241.20 – $969,991.20 from Flow Through (FT) units and $2,098,250 from Non-flow Through (NFT) units. The aggregate gross proceeds of the sale of the FT units will be used for contribution and maintenance of the company’s exploration work on its projects, particularly for the Hat Project. The aggregate gross proceeds from the sale of the NFT units will be used for exploration work on its projects, particularly for the Hat Project and for general administrative costs.
Champion Gaming Group Inc has said it intends to complete a non-brokered private placement of secured convertible promissory notes at a price of $1,000 per note for gross proceeds of up to C$800,000. The maturity date of the notes will be 24 months from the closing date. The holders of the notes will have the right, from time to time and at any time on or prior to the maturity date, to convert all or any portion of the outstanding principal amount (but not any accrued and unpaid interest) into common shares of the company, at a conversion price of $0.20 per common share. The notes will be secured by a general security agreement over assets of the company and the proceeds of the offering will be used for general working capital purposes.
Tiziana Life Sciences Ltd said it has appointed Dr Matthew Davis as its chief medical officer and acting chief scientific officer, effective immediately. The company noted that Dr Davis will report to Gabriele Cerrone, executive chairman and interim chief executive officer of Tiziana. “Dr Davis is a proven leader with 25 years in the pharmaceutical industry,” said Cerrone in a statement. “We believe Dr Davis’ experience with drug approvals is a key asset as the Company focuses more of its resources from discovery to proof-of-concept clinical trials. His broad therapeutic and FDA expertise, along with his in-depth experience with biologics will be invaluable as we pursue our mission to bring breakthrough therapies with the aim of treating Secondary-Progressive Multiple Sclerosis (SPMS), Crohn’s Disease and KRAS+ NSCLC and optimizing health outcomes.” “I am thrilled to join the Tiziana team, and for the opportunity to help advance Foralumab, TZLS-501 and Milciclib. I am energized to work with the passionate and dedicated R&D team and to meet the prestigious Scientific Advisors who are helping to guide the company,” Dr Davis added.
In a separate statement late on Friday, Tiziana Life Sciences said its board of directors has accepted the voluntary resignation of Dr Kunwar Shailubhai as its chief executive officer, chief scientific officer and board director, effective as of August 1, 2022. It said Dr Shailubhai resigned for personal reasons, and his resignation is not related to any disagreement with the company on any matter relating to the company’s operations, policies or practices. The company said its board has appointed Gabriele Cerrone, executive chairman of Tiziana, as interim chief executive officer to lead the company through this period of transition and will begin a search for a permanent chief executive officer and chief scientific officer immediately. “On behalf of the Board, I want to thank Kunwar for his many years of exceptional service to Tiziana and his commitment to our vision in providing locally acting antibody therapies to patients with unmet needs,” Cerrone said. “We wish Kunwar well in his future endeavors. We continue to advance our foralumab clinical development programs as planned, and will provide a progress update in due course,” he added.
enCore Energy Corp has announced that Gregory Zerzan has been appointed as its chief administrative officer and general counsel, effective July 15, 2022. The company noted that Zerzan is a proven executive and recognized legal expert on public and regulatory policies with more than 20 years of experience, most recently as the principal deputy solicitor of the United States Department of the Interior. “We are thrilled to welcome Gregory to our executive team,” said William M. Sheriff, executive chairman at enCore Energy in a statement. “Gregory brings a wealth of experience and expertise in public affairs and legislative and regulatory relations, having worked successfully in both the public and private sectors with a specialty in the energy and natural resources industries.”
Willow Biosciences Inc said its board of directors has appointed Dr Peter Seufer-Wasserthal as the company’s interim president and chief executive officer, effective July 17, 2022, following the retirement of Trevor Peters, who will remain as a director of Willow. The Vancouver-based company said in addition, Willow director Barbara Munroe has been appointed as lead independent director. “Peter is a visionary leader that has been chairman of the board of Willow since 2020,” Munroe said in a statement.
Graphene Manufacturing Group Ltd (GMG) has announced the appointment of chartered accountant Frederick Kotzee as its chief financial officer, effective 25 July, 2022. Kotzee joins GMG as an experienced CFO, having worked with a number of resource and industrial-related companies in Australia and South Africa, the clean technology company said. “I’m looking forward to Frederick’s contributions to a wide range of finance and business areas to support GMG’s ongoing development,” GMG CEO Craig Nicol said in a statement.
Agra Ventures Ltd has announced the resignation of Brian O’Neill as director of the company, effective immediately. The company said it would like to thank O’Neill for his time and service to AGRA and wish him well with his future endeavours.
Imperial Helium Corp said it has been granted the final court order from the Supreme Court of British Columbia approving the plan of arrangement with Royal Helium Ltd under the provisions of the Business Corporations Act (British Columbia) under which, Royal will acquire all of the issued and outstanding shares of Imperial Helium. Shareholders will receive 0.614 of a Royal common share for each Imperial Helium share held. Receipt of the final order follows approval of the arrangement Imperial shareholders at its special meeting on July 12, 2022. Assuming the satisfaction of all conditions, closing of the arrangement is expected to occur on or about July 22, 2022. Upon closing of the arrangement, Imperial Helium shareholders will be entitled to receive the consideration in exchange for each Imperial Helium share held. The transaction remains subject to final approval by the TSX Venture Exchange (TSX-V) and the satisfaction or waiver of conditions to closing. Following completion of the transaction, the common shares of Imperial Helium will be delisted from the TSXV.
BioHarvest Sciences Inc has announced that its common shares are now trading on the OTCQB Venture Market under the ticker symbol CNVCF. “Admission to the OTCQB market is an important step to increase US investor access to BioHarvest Sciences, and it provides US investors an additional level of transparency as we expand both our investor base and our customer base in North America,” said Bioharvest CEO Ilan Sobel. “We will continue to work on expanding our global visibility to investors to match the commercial entry of our products into new markets.”
Clean Seed Capital Group Ltd said it has entered into a loan agreement with Farm Credit Canada (FCC) to provide financing for the 2023 production run of the SMART Seeder MAX. “FCC has been a pillar of support for Clean Seed over the years,” said Graeme Lempriere, chief executive officer of Clean Seed. “We appreciate the work of the Winnipeg FCC team in supporting our 2023 program and beyond.” FCC is Canada’s leading agriculture and food lender, with a healthy loan portfolio of more than $44 billion. The self-sustaining Crown corporation is recognized as one of country’s top employers with more than 2,000 employees in offices across Canada. Under the loan agreement, Clean Seed may borrow $1,000,000 to fund production of the SMART Seeder MAX. Amounts borrowed bear interest of 8.45%, will be repayable from the proceeds of the sales of the 2023 SMART Seeder units and if not otherwise repaid prior, will be due September 1, 2023.
Stefan Gleason, a private investor, said he has acquired an additional 2% in outstanding shares of Electric Royalties Ltd, taking his stake in the company above 13%. On July 15, 2022, Gleason purchased 216,000 Electric Royalties shares via the OTCQB – at a cost of C$55,821, or an average of C$0.258 per share. Prior to July 15, he held an aggregate of 11,597,928 Electric Royalties common shares and 500,000 warrant shares, representing approximately 13.13% of the issued and outstanding shares on an as converted and partially diluted basis. After the purchases on July 15, Gleason held 11,813,928 Electric Royalties common shares and 500,000 warrant shares, or 13.37% of the issued and outstanding sares on an as converted and partially diluted basis. “I am excited to increase even further my investment in this undervalued company which has the benefit of cash in the bank and a first-mover advantage in the battery metals royalty space,” said Gleason in a statement. “Company management has demonstrated savvy, win-win deal-making abilities and communicates transparently to shareholders and the markets about the company’s ongoing progress. The future is bright for this business.”
AIM ImmunoTech Inc (AIM) announced that it received a notice on July 8, 2022, from Jonathan Jorgl, a stockholder who first purchased 1,000 AIM shares on June 27, 2022, seeking to nominate a control slate of two individuals for election to the three-member AIM board of directors at the 2022 Annual Meeting of Stockholders. It said the board has unanimously determined that the Jorgl notice is invalid due to numerous deficiencies including failure to comply with the company’s bylaws and accordingly it has been rejected. The company also announced that it has filed a complaint in the US District Court for the Middle District of Florida, Ocala Division, against seven defendants – including Jorgl, his nominees Robert Chioini and Michael Rice, as well as Franz Tudor, Todd Deutsch, Ted Kellner and Walter Lautz. AIM said it believes these individuals have failed to register as a group under US securities laws and have committed other unlawful actions in the context of their attempt to effectuate a takeover of the company’s board. Thomas K. Equels, AIM executive vice chairman of the board, CEO & president, commented: “We are taking these actions to protect the rights of all our stockholders. As the Board determined, the Jorgl Notice contains numerous deficiencies and false and misleading statements. Further, the Activist Group is composed of certain individuals with highly questionable and alarming backgrounds – including instances of insider trading, and breaches of corporate fiduciary duties. In this particular situation, they have wantonly disregarded US securities laws by failing to disclose required information and not making necessary filings. Allowing them to usurp control of the Board and the Company via a proxy contest, without paying a significant premium, would be a grave disservice to all stockholders. This type of hostile board takeover would also be highly detrimental to the patients we are striving to bring new life-saving oncology therapies to market to benefit and would jeopardize all the progress AIM’s management team has made over the past five years repurposing our lead drug, Ampligen, into oncology – and building upon the positive interim results in published data from preeminent cancer centers, which we are now seeing from our clinical trials. The Activist Group’s actions have left us with no choice but to proactively seek relief from the Court. We look forward to a speedy resolution of this matter so that we can return to fully focusing on advancing our pipeline of therapies to benefit patients and enhance stockholder value.”
Xigem Technologies Corporation has said it is proceeding with a consolidation of its issued and outstanding share capital on the basis of one new common share for every ten outstanding common shares. The company currently has 153,168,214 common shares issued and outstanding and following the consolidation, it will have approximately 15,316,821 shares issued and outstanding. No fractional shares will be issued under the Consolidation and any fraction will be rounded to the nearest whole number. The exercise or conversion price and/or the number of shares issuable under any of the Company’s outstanding convertible securities, stock options and warrants will be proportionally adjusted after based on the consolidation ratio (10:1). Subject to acceptance by the Canadian Securities Exchange (CSE), the shares are expected to begin trading on a post-consolidation basis on the CSE when markets open on July 21, 2022. The company’s name and trading symbol will not change. The company has been issued with a new CUSIP Number (98422W202). The company said its board of directors anticipates that the potential benefits of the consolidation include increased investor interest and reduced volatility. The consolidation was approved by the Company’s shareholders at its recent annual meeting held on April 13, 2022.
Regency Silver Corp said it has engaged M Partners to provide corporate advisory services to the company for a twelve-month period, under a service agreement entered into between the parties. M Partners is a full-service brokerage firm with its head office in Toronto, Ontario. Under the terms of the agreement, the company will issue 500,000 common shares to M Partners at a deemed price of $0.10 per share. The issuance of the common shares is subject to the approval of the TSX Venture Exchange (TSXV) and will have a hold period in accordance with TSXV policies. No new insiders will be created, nor will any change of control occur as a result of the issuance of common shares under the agreement.
In a separate statement, Regency Silver said it has granted stock options to acquire a total of 1,900,000 common shares of the company to directors, officers, employees, and consultants at a price of $0.07, subject to vesting requirements. All options were granted under the company’s stock option plan and are subject to the terms of the applicable grant agreements and the requirements of the TSX Venture Exchange. The options expire five years from the date of the grant, subject to the optionees continuing to act as directors, officers, employees or consultants of the company. The company also said it has cancelled 750,000 stock options previously held by certain directors under its stock option plan. The options had been granted on April 26, 2022, at an exercise price of $0.25 and the expiry date was April 26, 2027. The options were voluntarily surrendered by the holders for no consideration.
The Toronto Stock Exchange has reported that Nevada Copper Corp common share purchase warrants will be delisted at the close on July 29, 2022. According to the TSX, the warrants will expire at 5.00pm. Vancouver time on the same day. with 10 warrants exercisable at $2.20 per common share until the expiry time.
